| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |